TY - JOUR

T1 - Kordotsentez v antenatal'noi diagnostike, terapii i khirurgii bolezni ploda.

AU - Ailamazian, E. K.

PY - 1998

Y1 - 1998

N2 - Introduction of cordocentesis into clinical practice has made progress in antenatal diagnosis and treatment of congenital (hereditary and acquired) fetal diseases. Cytogenetic, molecular biological, biochemical, and immunological studies of fetal blood have substantial advantages for prenatal diagnosis. Direct administration of blood components and drugs into fetal blood circulation is the treatment of choice in some fetal diseases, severe types of hemolytic disease. Intravascular injection of myorelaxants was shown to greatly favour long-term intrauterine interventions. The potentialities, advances, and prospects of intrauterine surgical correction of fetal developmental disorders are discussed.

AB - Introduction of cordocentesis into clinical practice has made progress in antenatal diagnosis and treatment of congenital (hereditary and acquired) fetal diseases. Cytogenetic, molecular biological, biochemical, and immunological studies of fetal blood have substantial advantages for prenatal diagnosis. Direct administration of blood components and drugs into fetal blood circulation is the treatment of choice in some fetal diseases, severe types of hemolytic disease. Intravascular injection of myorelaxants was shown to greatly favour long-term intrauterine interventions. The potentialities, advances, and prospects of intrauterine surgical correction of fetal developmental disorders are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0031603361&partnerID=8YFLogxK

M3 - Обзорная статья

C2 - 9511433

AN - SCOPUS:0031603361

SP - 6

EP - 11

JO - ВЕСТНИК РОССИЙСКОЙ АКАДЕМИИ МЕДИЦИНСКИХ НАУК

JF - ВЕСТНИК РОССИЙСКОЙ АКАДЕМИИ МЕДИЦИНСКИХ НАУК

SN - 0869-6047

IS - 1

ER -